Related Experiment Video
Updated: Apr 19, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Polymorphisms in the PTX1 may not be associated with ischemic stroke susceptibility
1Department of Neurology, Beijing Chao-Yang Hospital, Capital Medical University Beijing, China.
Genetic variations in the PTX1 gene, specifically SNPs -717A>G and -286C>T>A, were investigated for their association with ischemic stroke risk. This study found no significant link between these PTX1 gene polymorphisms and an increased susceptibility to ischemic stroke.
Area of Science:
- Genetics
- Neurology
- Epidemiology
Background:
- Ischemic stroke represents a significant global health challenge with high incidence and mortality rates.
- Understanding the genetic underpinnings of ischemic stroke is crucial for potential diagnostic and prognostic advancements.
- The heterogeneity of ischemic stroke necessitates etiological research, including genetic factors.
Purpose of the Study:
- To investigate the association between specific PTX1 gene single nucleotide polymorphisms (SNPs), namely -717A>G and -286C>T>A, and the risk of developing ischemic stroke.
- To contribute to the etiological understanding of ischemic stroke by examining the role of PTX1 gene variations.
Main Methods:
- A meta-analysis approach was employed to estimate the risk of ischemic stroke associated with PTX1 SNPs.
- Summary odds ratios (ORs) were calculated using a fixed-effects model.
- Statistical analysis was performed using STATA software, combining data from 4,604 subjects for SNP -717A>G and 3,093 subjects for SNP -286C>T>A.
Main Results:
- The PTX1 SNP -717A>G showed no statistically significant association with ischemic stroke risk across various comparison models (e.g., GG vs. AA, OR = 1.12; GG + GA vs. AA, OR = 1.04).
- Similarly, the PTX1 SNP -286C>T>A did not demonstrate a significant association with ischemic stroke risk in the meta-analysis (e.g., AA vs. CC, OR = 0.86; AA vs. CC, OR = 0.92).
- Heterogeneity tests (PHet) indicated no significant heterogeneity in the pooled estimates for both SNPs.
Conclusions:
- The findings suggest that the investigated PTX1 gene polymorphisms (-717A>G and -286C>T>A) are unlikely to be associated with an increased predisposition to ischemic stroke.
- Further research may be warranted to explore other genetic factors or environmental influences on ischemic stroke risk.
More Related Videos
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Ischemic Stroke l: Introduction

